PhRMA lays out positions as Japan considers health tech assessment and vaccines policies
This article was originally published in Scrip
Executive Summary
Amid intensifying official discussions in Japan on various healthcare issues including a more formal methodology for health technology assessment (HTA), the US innovator industry association PhRMA has reiterated the need for a balanced approach that takes into account the wider benefits of medicines and their role in the system.